Myricetin also reduces iron uptake in Caco-2 cells [137] and the iron content in vivo by inhibiting the expression of transferrin receptor 1 (TFR1) in an Alzheimer’s disease mouse model [138]. This evidence concerns the gene TFRC and Alzheimer disease.